Enanta Pharmaceuticals Inc. buy Westpark Capital
Start price
30.09.25
/
50%
€10.60
Target price
30.09.26
€23.89
Performance (%)
4.72%
Price
09.01.26
€11.10
Summary
This prediction is currently active. With a performance of 4.72%, the BUY prediction by Westpark_Capital for Enanta Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 30.09.26. The prediction end date can be changed by Westpark_Capital at any time. Westpark_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -4.310% | -4.310% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by Westpark_Capital for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) had its price target raised by analysts at Westpark Capital from $24.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Westpark_Capital for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.60
02.09.25
02.09.25
€20.51
02.09.26
02.09.26
46.05%
09.01.26
09.01.26

